MX363963B - Composiciones de mentol liquidas. - Google Patents

Composiciones de mentol liquidas.

Info

Publication number
MX363963B
MX363963B MX2015009829A MX2015009829A MX363963B MX 363963 B MX363963 B MX 363963B MX 2015009829 A MX2015009829 A MX 2015009829A MX 2015009829 A MX2015009829 A MX 2015009829A MX 363963 B MX363963 B MX 363963B
Authority
MX
Mexico
Prior art keywords
menthol
composition
oil
edible oil
liquid
Prior art date
Application number
MX2015009829A
Other languages
English (en)
Other versions
MX2015009829A (es
Inventor
George Vieth Simon
James Temovsky Chris
William Vieth Reinhold
Original Assignee
Ddrops Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ddrops Company filed Critical Ddrops Company
Publication of MX2015009829A publication Critical patent/MX2015009829A/es
Publication of MX363963B publication Critical patent/MX363963B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1475—Inlet or outlet ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Edible Oils And Fats (AREA)

Abstract

La presente invención se refiere a una composición de fase líquida, individual, caracterizada porque consiste de: (i) 5-42.3% de mentol en peso total, y (ii) un aceite digestible, en donde el aceite digestible es un triglicérido de cadena mediana, de modo que la composición es un líquido a 20 °C después de elevar hasta esa temperatura desde una temperatura de 4 °C.
MX2015009829A 2013-02-01 2014-01-31 Composiciones de mentol liquidas. MX363963B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361759839P 2013-02-01 2013-02-01
PCT/CA2014/000090 WO2014117265A1 (en) 2013-02-01 2014-01-31 Liquid menthol compositions

Publications (2)

Publication Number Publication Date
MX2015009829A MX2015009829A (es) 2016-04-07
MX363963B true MX363963B (es) 2019-04-09

Family

ID=51261350

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009829A MX363963B (es) 2013-02-01 2014-01-31 Composiciones de mentol liquidas.

Country Status (16)

Country Link
US (1) US9999602B2 (es)
EP (1) EP2950823B1 (es)
JP (1) JP6552414B2 (es)
KR (1) KR102187731B1 (es)
CN (1) CN105324130A (es)
AU (1) AU2014211953B2 (es)
BR (1) BR112015018275B1 (es)
CA (1) CA2899250C (es)
ES (1) ES2821793T3 (es)
MX (1) MX363963B (es)
NZ (1) NZ710769A (es)
PL (1) PL2950823T3 (es)
PT (1) PT2950823T (es)
RU (1) RU2666997C2 (es)
WO (1) WO2014117265A1 (es)
ZA (1) ZA201505515B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201608943D0 (en) * 2016-05-20 2016-07-06 British American Tobacco Co Capsule for tobacco industry product
EP3585462A1 (en) * 2018-01-25 2020-01-01 Biogastrex LLC Insufflation system
GB201809627D0 (en) * 2018-06-12 2018-07-25 Biorelevant Com Ltd Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling
CA3176555A1 (en) 2020-01-31 2021-08-05 Arthur Goldberg Stabilized menthol and other volatile compound compositions and methods
MX2022012086A (es) 2020-03-30 2022-11-09 Sunsho Pharmaceutical Co Ltd Composicion con mentol.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106578A (en) * 1993-08-03 2000-08-13 Yissum Res Dev Co Pharmaceutical compositions for drug targeting
WO1998000168A1 (en) * 1996-07-02 1998-01-08 Novartis Consumer Health S.A. Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds
WO2000037044A1 (en) 1998-12-21 2000-06-29 Biovail International Ltd. Soft and chewy cough and cold relief composition
US20040071757A1 (en) * 2001-11-20 2004-04-15 David Rolf Inhalation antiviral patch
US7989503B2 (en) * 2002-05-22 2011-08-02 Nihon Pharmaceutical Co., Ltd. Smooth muscle peristole inhibitor
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
EP1562543A1 (en) * 2002-11-21 2005-08-17 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
CN102038963B (zh) * 2003-06-30 2013-09-11 日本制药株式会社 制备含有薄荷醇的乳剂的方法
US20070042007A1 (en) * 2005-08-19 2007-02-22 Joseph Schwarz Topical composition for delivery of salicylate esters
WO2007115593A1 (en) * 2006-04-11 2007-10-18 Symrise Gmbh & Co. Kg Composition of menthyl lactate and a mixture of menthol isomers
CA2558202A1 (en) * 2006-09-14 2006-11-23 Reinhold W. Vieth Vitamin d compositions and method of administration to infants
JP2008231049A (ja) * 2007-03-22 2008-10-02 Saburo Yasuda アポトーシス誘導物質
CA2711703A1 (en) * 2008-01-08 2009-07-16 Foamix Ltd. Sensation modifying topical composition foam
EP2692252B1 (en) * 2011-03-31 2018-06-06 Japan Tobacco, Inc. Cigarette
CA2745267C (en) * 2011-07-05 2019-09-24 Reinhold Vieth Iron supplement composition

Also Published As

Publication number Publication date
WO2014117265A1 (en) 2014-08-07
MX2015009829A (es) 2016-04-07
EP2950823A1 (en) 2015-12-09
RU2666997C2 (ru) 2018-09-13
PL2950823T3 (pl) 2021-02-08
AU2014211953A1 (en) 2015-08-20
ZA201505515B (en) 2016-10-26
AU2014211953B2 (en) 2018-08-02
CA2899250A1 (en) 2014-08-07
PT2950823T (pt) 2020-10-07
CN105324130A (zh) 2016-02-10
ES2821793T3 (es) 2021-04-27
JP2016506934A (ja) 2016-03-07
KR20150123813A (ko) 2015-11-04
RU2015137043A (ru) 2017-03-10
EP2950823A4 (en) 2016-10-19
JP6552414B2 (ja) 2019-07-31
US20150359753A1 (en) 2015-12-17
EP2950823B1 (en) 2020-07-01
BR112015018275A2 (pt) 2017-07-18
CA2899250C (en) 2021-11-23
US9999602B2 (en) 2018-06-19
NZ710769A (en) 2020-08-28
BR112015018275B1 (pt) 2021-10-19
KR102187731B1 (ko) 2020-12-07

Similar Documents

Publication Publication Date Title
PH12016500100A1 (en) Self-emulsifying composition of omega3 fatty acid
MX2017002626A (es) Composicion que contiene una mezcla de extractos vegetales o una mezcla de moleculas contenidas en dichas plantas y uso para controlar el metabolismo de glucidos y/o lipidos.
NZ710769A (en) Liquid menthol compositions
MX2017015037A (es) Composiciones nutritivas que contienen un nivel elevado de inositol y usos de las mismas.
BR112014027719A2 (pt) método para preparar um gel óleo comestível, gel óleo comestível, uso do gel óleo comestível, produto alimentício e uso de produto alimentício
BR112014029077A2 (pt) composições e métodos para aumentar a estabilidade de aditivos para produto alimentar
MY189030A (en) Fats and oils
MX351135B (es) Fluido dielectrico de aceite microbiano geneticamente diseñado.
PH12016501902B1 (en) Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed
MY173665A (en) Interesterified oils and fats, and oil based food including the interesterified oils and fats
MX2015013738A (es) Composicion rodenticida de cebo blando.
MX2016003619A (es) Composicion de grasa comestible.
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
PH12016501901B1 (en) Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed
MX349987B (es) Emulsión orgánica que comprende dha y epa.
NZ720512A (en) Multi-particulate drug delivery system
MX2017007230A (es) Composiciones y metodos que comprenden trigliceridos de cadena media para el tratamiento de la epilepsia.
SG10201810977XA (en) Dilute-type nutritional composition
NZ603428A (en) Synergistic composition of galactolipid in combination with ascorbic acid for protection against oxidation
MX2016013680A (es) Métodos y composiciones para el tratamiento de trastornos por el almacenamiento de lípidos.
MX2016014899A (es) Proceso para la manufactura de emulsion comestible agua en aceite.
PE20141705A1 (es) Composicion que confiere aroma y/o sabor, producto alimenticio y metodo de produccion para dicho producto alimenticio
WO2012108745A3 (ko) 조각인 추출물을 포함하는 뇌암 치료용 조성물 및 건강 기능성 식품
EA201890479A1 (ru) Гидрофобный гель на основе витамина е без продуктов силикона для местного применения
MY176560A (en) A method for delivering lipophilic nutrients from red palm olein

Legal Events

Date Code Title Description
FG Grant or registration